In recent months, the Horseracing Integrity & Welfare Unit (HIWU) has adjudicated several cases under the Anti-Doping and Medication Control (ADMC) Program related to adenosine, a vasodilator, and Hemo 15, a foreign product that lacks FDA approval, according to an advisory from HIWU, which says that neither substance has any valid veterinary use in the
The post HIWU Issues Horsemen’s Advisory Regarding Adenosine and Hemo 15 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.